glp-1 news november 5 2025 The Underappreciated Benefits of Receptor Agonists GLP-1 trends 2025: real-world data,

Weight regain is a possibility with both medications when treatment ends, which is why obesity is increasingly treated as a chronic condition that benefits from long-term, supervised care

As NAD+ levels decline with age, supplementing with NMN aims to replenish these crucial cellular energy molecules

For some patients, semaglutide may work well

I can tell you about the patients that I helped lose 50 pounds, that I helped lose 100 pounds, and they still look in the mirror and are not happy. The key is seeking help for mental health along the way, said Gerald Onuoha, who practices internal medicine in Nashville

Competing interests The authors declare no conflicts of interest